• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草药产品:在慢性肝病中的益处、限制和应用。

Herbal products: benefits, limits, and applications in chronic liver disease.

机构信息

Department of Clinical and Experimental Medicine, Interuniversity Research Centre on Food, Nutrition and the Gastrointestinal Tract (CIRANAD), 2nd University of Naples, 80131 Naples, Italy.

出版信息

Evid Based Complement Alternat Med. 2012;2012:837939. doi: 10.1155/2012/837939. Epub 2012 Sep 6.

DOI:10.1155/2012/837939
PMID:22991573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3443820/
Abstract

Complementary and alternative medicine soughts and encompasses a wide range of approaches; its use begun in ancient China at the time of Xia dynasty and in India during the Vedic period, but thanks to its long-lasting curative effect, easy availability, natural way of healing, and poor side-effects it is gaining importance throughout the world in clinical practice. We conducted a review describing the effects and the limits of using herbal products in chronic liver disease, focusing our attention on those most known, such as quercetin or curcumin. We tried to describe their pharmacokinetics, biological properties, and their beneficial effects (as antioxidant role) in metabolic, alcoholic, and viral hepatitis (considering that oxidative stress is the common pathway of chronic liver diseases of different etiology). The main limit of applicability of CAM comes from the lacking of randomized, placebo-controlled clinical trials giving a real proof of efficacy of those products, so that anecdotal success and personal experience are frequently the driving force for acceptance of CAM in the population.

摘要

补充和替代医学寻求并包含了广泛的方法;它的使用始于中国古代的夏朝和印度吠陀时期,但由于其持久的疗效、易于获得、自然的治疗方式和较少的副作用,它在世界范围内的临床实践中变得越来越重要。我们进行了一项综述,描述了在慢性肝病中使用草药产品的效果和限制,特别关注那些最知名的草药产品,如槲皮素或姜黄素。我们试图描述它们的药代动力学、生物学特性以及它们在代谢性、酒精性和病毒性肝炎中的有益作用(因为氧化应激是不同病因的慢性肝病的共同途径)。CAM 的主要应用限制来自缺乏随机、安慰剂对照的临床试验,这些试验无法真正证明这些产品的疗效,因此轶事成功和个人经验常常是 CAM 在人群中被接受的驱动力。

相似文献

1
Herbal products: benefits, limits, and applications in chronic liver disease.草药产品:在慢性肝病中的益处、限制和应用。
Evid Based Complement Alternat Med. 2012;2012:837939. doi: 10.1155/2012/837939. Epub 2012 Sep 6.
2
Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs.用于肝纤维化的草药疗法:五十种草药作用模式综述
J Tradit Complement Med. 2017 Nov 22;8(3):352-360. doi: 10.1016/j.jtcme.2017.07.002. eCollection 2018 Jul.
3
A recent update in research on the antihepatotoxic potential of medicinal plants.药用植物抗肝毒性潜力的最新研究进展。
Zhong Xi Yi Jie He Xue Bao. 2012 Feb;10(2):117-27. doi: 10.3736/jcim20120201.
4
Use of complementary and alternative medicine in patients with chronic viral hepatitis in Turkey.土耳其慢性病毒性肝炎患者对补充替代医学的应用。
Complement Ther Med. 2020 Jan;48:102229. doi: 10.1016/j.ctim.2019.102229. Epub 2019 Nov 3.
5
Herbal medicines for fatty liver diseases.用于治疗脂肪肝疾病的草药
Cochrane Database Syst Rev. 2013 Aug 24(8):CD009059. doi: 10.1002/14651858.CD009059.pub2.
6
Herbal medicines for liver diseases in India.印度治疗肝病的草药
J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S370-6. doi: 10.1046/j.1440-1746.17.s3.30.x.
7
Complementary/alternative medicine in the treatment of asthma.补充和替代医学在哮喘治疗中的应用
Ann Allergy Asthma Immunol. 2000 Dec;85(6 Pt 1):438-47; quiz 447-9. doi: 10.1016/S1081-1206(10)62569-0.
8
Chinese medicine for treatment of chronic hepatitis B.中医治疗慢性乙型肝炎。
Chin J Integr Med. 2012 Apr;18(4):253-5. doi: 10.1007/s11655-012-1064-4. Epub 2012 Mar 30.
9
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.中药复方抗肝纤维化治疗的研究进展。
J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28.
10
Complementary & alternative management of Parkinson's disease: an evidence-based review of eastern influenced practices.帕金森病的补充和替代管理:受东方影响的实践的循证综述。
J Mov Disord. 2014 Oct;7(2):57-66. doi: 10.14802/jmd.14009. Epub 2014 Oct 30.

引用本文的文献

1
Antiviral potential of Melissa officinalis extracts against influenza and emerging coronaviruses.蜜蜂花提取物对流感病毒和新兴冠状病毒的抗病毒潜力。
Sci Rep. 2025 Apr 9;15(1):12118. doi: 10.1038/s41598-025-96417-5.
2
Effects of propolis supplementation on prooxidant-antioxidant balance, oxidative stress biomarkers, and body composition in obese patients with NAFLD: A double-blind randomized controlled clinical trial.补充蜂胶对非酒精性脂肪性肝病肥胖患者的促氧化剂-抗氧化剂平衡、氧化应激生物标志物及身体成分的影响:一项双盲随机对照临床试验
Health Promot Perspect. 2024 Oct 31;14(3):286-296. doi: 10.34172/hpp.42549. eCollection 2024.
3
Advancements in Plant-Based Therapeutics for Hepatic Fibrosis: Molecular Mechanisms and Nanoparticulate Drug Delivery Systems.植物药治疗肝纤维化的研究进展:分子机制与纳米给药系统。
Int J Mol Sci. 2024 Aug 28;25(17):9346. doi: 10.3390/ijms25179346.
4
Bridging the Gap: Exploring the Preclinical Potential of in Metabolic-Associated Fatty Liver Disease.弥合差距:探索[具体内容]在代谢相关脂肪性肝病中的临床前潜力。 (原文中“in Metabolic-Associated Fatty Liver Disease”前缺少具体内容)
Evid Based Complement Alternat Med. 2023 Nov 9;2023:8840427. doi: 10.1155/2023/8840427. eCollection 2023.
5
Green Alternatives as Antimicrobial Agents in Mitigating Periodontal Diseases: A Narrative Review.绿色替代物作为减轻牙周疾病的抗菌剂:一项叙述性综述
Microorganisms. 2023 May 11;11(5):1269. doi: 10.3390/microorganisms11051269.
6
Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics.理解纳米技术在肝纤维化中的潜在作用:治疗学的范例。
Molecules. 2023 Mar 20;28(6):2811. doi: 10.3390/molecules28062811.
7
(Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology.(甘草):关于其植物化学、生物活性、临床证据和毒理学的综合综述
Plants (Basel). 2021 Dec 14;10(12):2751. doi: 10.3390/plants10122751.
8
Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF- and TLR4 Signaling Pathways.抗纤软肝胶囊通过调节转化生长因子和Toll样受体4信号通路对非酒精性脂肪性肝纤维化大鼠及肝星状细胞的抗纤维化作用
Evid Based Complement Alternat Med. 2021 Aug 10;2021:5649575. doi: 10.1155/2021/5649575. eCollection 2021.
9
Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients.在有症状的自身免疫性肝炎患者中,补充和替代医学的利用和影响。
Dig Dis Sci. 2022 Jul;67(7):2891-2898. doi: 10.1007/s10620-021-07112-0. Epub 2021 Jun 23.
10
Aflatoxicosis in Pekin duckling and the effects of treatments with lycopene and silymarin.北京鸭雏鸭的黄曲霉毒素中毒及番茄红素和水飞蓟宾治疗的效果
Vet World. 2021 Mar;14(3):788-793. doi: 10.14202/vetworld.2021.788-793. Epub 2021 Mar 29.

本文引用的文献

1
Quercetin prevents ethanol-induced dyslipidemia and mitochondrial oxidative damage.槲皮素可预防乙醇诱导的血脂异常和线粒体氧化损伤。
Food Chem Toxicol. 2012 May;50(5):1194-200. doi: 10.1016/j.fct.2012.02.008. Epub 2012 Feb 16.
2
Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway.甘草酸通过抑制 p38 依赖的线粒体途径减轻 HMGB1 诱导的肝细胞凋亡。
World J Gastroenterol. 2012 Feb 21;18(7):679-84. doi: 10.3748/wjg.v18.i7.679.
3
Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats.评价槲皮素在大鼠酒精性神经病实验模型中的改善作用。
Inflammopharmacology. 2012 Dec;20(6):331-41. doi: 10.1007/s10787-012-0122-z. Epub 2012 Feb 14.
4
Synthesis and antiviral evaluation of 7-O-arylmethylquercetin derivatives against SARS-associated coronavirus (SCV) and hepatitis C virus (HCV).7-O-芳甲基槲皮素衍生物的合成及其抗 SARS 相关冠状病毒(SCV)和丙型肝炎病毒(HCV)的抗病毒活性评价。
Arch Pharm Res. 2012 Jan;35(1):77-85. doi: 10.1007/s12272-012-0108-9. Epub 2012 Feb 2.
5
Phenotypic and functional maturation of murine dendritic cells (DCs) induced by purified Glycyrrhizin (GL).GL 诱导的小鼠树突状细胞(DCs)的表型和功能成熟。
Int Immunopharmacol. 2012 Mar;12(3):518-25. doi: 10.1016/j.intimp.2012.01.006. Epub 2012 Jan 29.
6
Evaluation of the immunity activity of glycyrrhizin in AR mice.甘草酸对 AR 模型小鼠免疫活性的评价。
Molecules. 2012 Jan 12;17(1):716-27. doi: 10.3390/molecules17010716.
7
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.槲皮素通过抑制 NS3 蛋白酶活性抑制丙型肝炎病毒。
J Viral Hepat. 2012 Feb;19(2):e81-8. doi: 10.1111/j.1365-2893.2011.01507.x. Epub 2011 Aug 16.
8
β-Cyclodextrin/glycyrrhizic acid functionalised quantum dots selectively enter hepatic cells and induce apoptosis.β-环糊精/甘草酸功能化量子点选择性进入肝细胞并诱导细胞凋亡。
Chemistry. 2012 Feb 6;18(6):1650-8. doi: 10.1002/chem.201102795. Epub 2012 Jan 2.
9
18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells.18α-甘草酸苷诱导大鼠肝星状细胞凋亡并抑制其活化。
Med Sci Monit. 2012 Jan;18(1):BR24-32. doi: 10.12659/msm.882196.
10
Antihepatotoxic activity of Phyllanthus atropurpureus cultivated in Egypt.埃及种植的显脉榕的抗肝毒性活性。
Z Naturforsch C J Biosci. 2011 Sep-Oct;66(9-10):447-52. doi: 10.1515/znc-2011-9-1002.